SCHEMBL1413330

SCHEMBL1413330

CC(=O)c1cn(S(=O)(=O)c2ccc(C(=O)NCc3ccc(F)cc3)cc2)c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
PLK1 P53350 1/20 0.54
CXCR4 P61073 1/20 0.52
POLB P06746 1/20 0.51
TNFSF11 O14788 2/20 0.51
TNF P01375 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
ALOX5 P09917 2/20 0.48
PTGS2 P35354 1/20 0.48
ALDH1A1 P00352 1/20 0.47
HTR6 P50406 1/20 0.47
AKR1C3 P42330 1/20 0.47
AKR1C1 Q04828 1/20 0.47
RORC P51449 3/20 0.46
MAPT P10636 1/20 0.46
CCR1 P32246 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1413705 0.88 CXCR4 (0.54) LMNAPLK1CXCR4MEN1KMT2A
SCHEMBL1413685 0.86 CXCR4 (0.52) LMNACXCR4TNFSF11MEN1KMT2A
SCHEMBL1413405 0.86 CXCR4 (0.52) LMNAPLK1CXCR4MEN1KMT2A
SCHEMBL1413324 0.86 CXCR4 (0.54) LMNAPLK1CXCR4TNFSF11MEN1
SCHEMBL1413651 0.86 CXCR4 (0.54) LMNACXCR4TNFSF11MEN1KMT2A
SCHEMBL1413511 0.85 HTR6 (0.52) PLK1CXCR4TNFSF11TNFALDH1A1
SCHEMBL4006350 0.85 CXCR4 (0.51) LMNAPLK1CXCR4TNFSF11TNF
SCHEMBL1413828 0.85 HTR6 (0.58) LMNAPLK1CXCR4TNFSF11MEN1
SCHEMBL1413872 0.84 CXCR4 (0.50) LMNAPLK1CXCR4MEN1KMT2A
SCHEMBL1413472 0.84 HTR6 (0.58) LMNACXCR4MEN1KMT2AHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1699761-B1 CB1 MODULATOR COMPOUNDS LILLY CO ELI (US) 2011-03-16 EP disclosed
EP-1699761-B1 CB1 MODULATOR COMPOUNDS LILLY CO ELI (US) 2011-03-16 EP disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-7595339-B2 CB1 modulator compounds ELI LILLY AND COMPANY (US) 2009-09-29 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-20080287504-A1 CB1 MODULATOR COMPOUNDS ALLEN JENNIFER REBECCA 2008-11-20 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-7276516-B2 CB1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-10-02 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed
US-20070088018-A1 Cb1 antagonist compounds ELI LILLY AND COMPANY (US) 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088018-A1 Cb1 antagonist compounds CNR1, CNR2, CHRNA5 LMNA 1948/4885SMN1; SMN2 546/4885PLK1 4265/4885
US-20080287504-A1 CB1 MODULATOR COMPOUNDS CNR1, CNR2, MAG LMNA 2183/4885SMN1; SMN2 628/4885PLK1 4210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.